Shilpa Medicare Declares Unaudited Q1 FY27 Results
Shilpa Medicare Ltd announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The Board of Directors approved these results during a meeting held on August 5, 2026. The company also announced the appointment of a new Whole-time Director, subject to member approval, and the payment of remuneration to a Non-Executive Director of a material subsidiary. Additionally, details regarding a strategic long-term equity partnership involving a wholly-owned subsidiary and an investment of up to EUR 7 million were shared. The 39th Annual General Meeting is scheduled for September 11, 2026, with September 4, 2026, set as the record date for determining dividend entitlement and e-voting eligibility.
Key Highlights
- Unaudited standalone and consolidated financial results for Q1 FY27 declared.
- Board meeting held on August 5, 2026, approved the financial results.
- Appointment of Mr. Sharath Reddy Kalakota as Whole-time Director approved.
- Strategic equity partnership involving a subsidiary and EUR 7 million investment confirmed.
- 39th AGM scheduled for September 11, 2026; record date set for September 4, 2026.
Price Impact
More from SHILPAMED